Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
VBR vs XLV: how they differ
VBR and XLV hold 3% of their weight in the same names, and XLV returned more over the year.
Vanguard Small-Cap Value Index Fund and State Street(R) Health Care Select Sector SPDR(R) ETF.
What they hold in common
By the books each fund has filed, VBR and XLV hold 3% of their money in the same securities at the same weight.
| Holding | VBR | XLV |
|---|---|---|
| Moderna Inc | 0.54% | 0.43% |
| Centene Corp | 0.34% | 0.53% |
| Viatris Inc | 0.40% | 0.32% |
| Cooper Cos Inc/The | 0.30% | 0.24% |
| Revvity Inc | 0.27% | 0.22% |
| Solventum Corp | 0.24% | 0.20% |
| Align Technology Inc | 0.25% | 0.20% |
| Baxter International Inc | 0.24% | 0.19% |
| Charles River Laboratories International | 0.23% | 0.19% |
| Zimmer Biomet Holdings Inc | 0.18% | 0.29% |
| Henry Schein Inc | 0.17% | 0.14% |
| Universal Health Services Inc | 0.16% | 0.14% |
| Only in VBR | Only in XLV |
|---|---|
| Jabil Inc 0.87% | Eli Lilly & Co 16.56% |
| NRG Energy Inc 0.66% | Johnson & Johnson 10.67% |
| Tapestry Inc 0.64% | AbbVie Inc 7.76% |
| Atmos Energy Corp 0.62% | UnitedHealth Group Inc 6.59% |
| Williams-Sonoma Inc 0.59% | Merck & Co Inc 5.54% |
| Smurfit Westrock PLC 0.52% | Amgen Inc 3.41% |
| F5 Inc 0.50% | Thermo Fisher Scientific Inc 3.25% |
| US Foods Holding Corp 0.48% | Abbott Laboratories 2.76% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.
| VBR Vanguard Small-Cap Value Index Fund | XLV State Street(R) Health Care Select Sector SPDR(R) ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | Vanguard | State Street |
| What it is | Small-Cap Value | Health care |
| Total return, 1 year | +16.3% | +20.4% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | −1.2 pts | +2.9 pts |
| Expense ratio | 0.05% | 0.08% |
| Already in the S&P 500 | 30.5% | 100.0% |
| Holdings | 840 | 59 |
VBR in plain words
VBR is an index equity fund tracking the Small-Cap Value. Over the year to Sep 11, 2026 it returned +16.3% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.05% a year. By its holdings filed for Jun 30, 2026, 30% of the fund by weight is stocks the S&P 500 also holds, across 840 positions, with the top ten at 5.9%. It sat 3.8% below its high of Aug 14, 2026 on Sep 11, 2026.
XLV in plain words
XLV is an index equity fund tracking the Health care. Over the year to Sep 11, 2026 it returned +20.4% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%. It sat 5.9% below its high of Aug 19, 2026 on Sep 11, 2026.
Questions people ask
- Which returned more over the last year, VBR or XLV?
- In the year to Sep 12, 2026, with distributions reinvested, VBR returned +16.3% and XLV returned +20.4%, so XLV returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, VBR or XLV?
- VBR charges 0.05% a year and XLV charges 0.08%, so VBR is cheaper. Fees come from each fund's prospectus.
- How much do VBR and XLV overlap with the S&P 500?
- By their latest filed holdings, 30% of VBR and 100% of XLV by weight is stocks the S&P 500 already holds. Between the two funds, 3% of their books are the same securities at the same weight.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, VBR against XLV, data as of Sep 12, 2026. https://etfiq.com/compare/any/VBR-XLV Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources